Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir.

Journal of chemotherapy (Florence, Italy) - 1 Aug 2009

d'Ettorre G, Ceccarelli G, Turriziani O, Andreotti M, Massetti P, Rizza C, Vella S, Antonelli G, Mastroianni C M, Vullo V

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to Drug Combinations
Share to Lamivudine
Share to Leukocytes, Mononuclear

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Organophosphonates

Share to Tenofovir

Share to Viremia

Share to Zidovudine

Source

Identifiers

PMID: 19622468
DOI: 10.1179/joc.2009.21.4.455

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir.PMID 19622468Read ↗

An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy.Semantic proximity Read ↗

No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments.Semantic proximity Read ↗

Differential genotypic evolution of HIV-1 quasispecies in cerebrospinal fluid and plasma: a systematic review.Semantic proximity Read ↗

Ongoing HIV replication in cerebrospinal fluid under successful monotherapy.Semantic proximity Read ↗

Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma.Semantic proximity Read ↗

Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders.Semantic proximity Read ↗

Selection of an M184V mutation in the cerebrospinal fluid of a treatment-naive HIV-infected individual starting darunavir-based therapy.Semantic proximity Read ↗

The utility of cerebrospinal fluid for the molecular diagnosis of toxoplasmic encephalitisSemantic proximity Read ↗

Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States.Semantic proximity Read ↗

Discordant Human Immunodeficiency Virus Type 1 drug resistance mutations, including K103N, observed in cerebrospinal fluid and plasma.Semantic proximity Read ↗

The presence of resistance-associated mutations in reverse transcriptase gene is associated with cerebrospinal fluid HIV-1 escape: A multicentric retrospective analysis.Semantic proximity Read ↗

Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebrospinal fluid and plasma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.